1380. Real-world Effectiveness and Complications of Valganciclovir (VGC) Prophylaxis for Kidney Transplant (KT) Recipients at High Risk for Cytomegalovirus (CMV) infection (CMV Donor (D)+/Recipient (R)-)

BACKGROUND: CMV infection is common post-kidney transplant (KT). Valganciclovir (VGC) prophylaxis (Px) has lessened CMV infection among high-risk (CMV D+/R-) KT recipients (KTRs), but VGC can induce neutropenia. We quantified the burden of CMV infection among CMV D+/R- KTRs and healthcare resources...

Descripción completa

Detalles Bibliográficos
Autores principales: Roumpz, Caroline G, Kohl, Josh, Hughes, Kailey L, Raval, Amit D, Tang, Yuexin, Clancy, Cornelius J, Nguyen, Minh-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644623/
http://dx.doi.org/10.1093/ofid/ofab466.1572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644623/
http://dx.doi.org/10.1093/ofid/ofab466.1572

Ejemplares similares